Concepts (132)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Premature Birth | 1 | 2022 | 105 | 0.740 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 1 | 2022 | 166 | 0.720 |
Why?
|
| Autism Spectrum Disorder | 2 | 2017 | 178 | 0.500 |
Why?
|
| Gyrus Cinguli | 1 | 2015 | 57 | 0.490 |
Why?
|
| Glutamine | 1 | 2015 | 47 | 0.480 |
Why?
|
| gamma-Aminobutyric Acid | 1 | 2015 | 79 | 0.480 |
Why?
|
| Emotional Intelligence | 1 | 2013 | 4 | 0.450 |
Why?
|
| Schizophrenic Psychology | 1 | 2013 | 65 | 0.430 |
Why?
|
| Oxytocin | 1 | 2013 | 49 | 0.430 |
Why?
|
| Cognition | 2 | 2023 | 456 | 0.420 |
Why?
|
| Child Development Disorders, Pervasive | 1 | 2013 | 52 | 0.420 |
Why?
|
| Mental Disorders | 2 | 2023 | 763 | 0.390 |
Why?
|
| Psychotic Disorders | 1 | 2013 | 150 | 0.380 |
Why?
|
| Schizophrenia | 1 | 2013 | 256 | 0.370 |
Why?
|
| Lens, Crystalline | 1 | 2007 | 15 | 0.300 |
Why?
|
| Cranial Irradiation | 1 | 2007 | 11 | 0.300 |
Why?
|
| Central Nervous System Neoplasms | 1 | 2007 | 37 | 0.290 |
Why?
|
| Resilience, Psychological | 2 | 2018 | 50 | 0.290 |
Why?
|
| Tissue Culture Techniques | 1 | 2006 | 31 | 0.270 |
Why?
|
| Biomimetics | 1 | 2006 | 28 | 0.270 |
Why?
|
| Oxygen | 1 | 2006 | 301 | 0.240 |
Why?
|
| Stem Cells | 1 | 2006 | 254 | 0.230 |
Why?
|
| Glucose | 1 | 2006 | 440 | 0.220 |
Why?
|
| Fragile X Syndrome | 1 | 2022 | 27 | 0.200 |
Why?
|
| Infant, Newborn | 2 | 2023 | 1299 | 0.190 |
Why?
|
| Petroleum Pollution | 2 | 2018 | 3 | 0.190 |
Why?
|
| Models, Biological | 1 | 2006 | 1136 | 0.190 |
Why?
|
| Emotions | 1 | 2023 | 216 | 0.180 |
Why?
|
| Cyclonic Storms | 2 | 2018 | 23 | 0.180 |
Why?
|
| Social Capital | 1 | 2018 | 5 | 0.160 |
Why?
|
| Loneliness | 1 | 2018 | 18 | 0.160 |
Why?
|
| Disasters | 1 | 2018 | 28 | 0.150 |
Why?
|
| Humans | 14 | 2023 | 58814 | 0.150 |
Why?
|
| Outpatient Clinics, Hospital | 1 | 2017 | 39 | 0.150 |
Why?
|
| Survivors | 1 | 2018 | 148 | 0.150 |
Why?
|
| Child | 4 | 2023 | 4237 | 0.140 |
Why?
|
| Adolescent | 4 | 2023 | 5862 | 0.140 |
Why?
|
| Creatinine | 1 | 2015 | 121 | 0.120 |
Why?
|
| Intelligence | 1 | 2015 | 56 | 0.120 |
Why?
|
| Biomedical Research | 1 | 2017 | 247 | 0.120 |
Why?
|
| Depression | 2 | 2018 | 851 | 0.120 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2015 | 290 | 0.110 |
Why?
|
| Psychopathology | 1 | 2013 | 20 | 0.110 |
Why?
|
| Oxytocics | 1 | 2013 | 15 | 0.110 |
Why?
|
| Communication Disorders | 1 | 2013 | 16 | 0.110 |
Why?
|
| Epigenomics | 1 | 2013 | 54 | 0.110 |
Why?
|
| Age of Onset | 1 | 2013 | 172 | 0.110 |
Why?
|
| Diagnostic and Statistical Manual of Mental Disorders | 1 | 2013 | 123 | 0.110 |
Why?
|
| Child Behavior | 1 | 2013 | 67 | 0.100 |
Why?
|
| Social Behavior | 1 | 2013 | 88 | 0.100 |
Why?
|
| Psychotropic Drugs | 1 | 2013 | 83 | 0.100 |
Why?
|
| Interpersonal Relations | 1 | 2013 | 150 | 0.100 |
Why?
|
| Biomarkers | 1 | 2017 | 1199 | 0.100 |
Why?
|
| Female | 6 | 2023 | 30539 | 0.100 |
Why?
|
| Male | 7 | 2023 | 27252 | 0.100 |
Why?
|
| Mobile Applications | 1 | 2013 | 124 | 0.090 |
Why?
|
| Social Media | 1 | 2013 | 110 | 0.090 |
Why?
|
| Psychiatry | 1 | 2013 | 129 | 0.090 |
Why?
|
| Autistic Disorder | 1 | 2013 | 167 | 0.090 |
Why?
|
| Diagnosis, Differential | 1 | 2013 | 893 | 0.090 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2013 | 662 | 0.090 |
Why?
|
| Comorbidity | 1 | 2013 | 1083 | 0.080 |
Why?
|
| Practice Guidelines as Topic | 1 | 2013 | 701 | 0.080 |
Why?
|
| Mississippi | 2 | 2018 | 33 | 0.080 |
Why?
|
| Child, Preschool | 2 | 2017 | 1811 | 0.080 |
Why?
|
| Cerebellar Neoplasms | 1 | 2007 | 9 | 0.070 |
Why?
|
| Medulloblastoma | 1 | 2007 | 11 | 0.070 |
Why?
|
| Proton Therapy | 1 | 2007 | 10 | 0.070 |
Why?
|
| Radiation Injuries | 1 | 2007 | 56 | 0.070 |
Why?
|
| Radiation Dosage | 1 | 2007 | 120 | 0.070 |
Why?
|
| Metabolic Clearance Rate | 1 | 2006 | 41 | 0.070 |
Why?
|
| Pregnancy Proteins | 1 | 2006 | 17 | 0.070 |
Why?
|
| Neoplasms, Experimental | 1 | 2006 | 73 | 0.060 |
Why?
|
| Platelet-Derived Growth Factor | 1 | 2005 | 19 | 0.060 |
Why?
|
| Receptor, Platelet-Derived Growth Factor beta | 1 | 2005 | 13 | 0.060 |
Why?
|
| Lymphokines | 1 | 2005 | 66 | 0.060 |
Why?
|
| Carcinoma, Renal Cell | 1 | 2005 | 75 | 0.060 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2006 | 201 | 0.060 |
Why?
|
| Kinetics | 1 | 2006 | 728 | 0.060 |
Why?
|
| Kidney Neoplasms | 1 | 2005 | 114 | 0.060 |
Why?
|
| Computer Simulation | 1 | 2006 | 447 | 0.060 |
Why?
|
| Age Factors | 1 | 2007 | 1514 | 0.050 |
Why?
|
| Hair Follicle | 1 | 2022 | 29 | 0.050 |
Why?
|
| Fragile X Mental Retardation Protein | 1 | 2022 | 36 | 0.050 |
Why?
|
| Cell Proliferation | 1 | 2006 | 936 | 0.050 |
Why?
|
| Cells, Cultured | 1 | 2006 | 2090 | 0.050 |
Why?
|
| Adult | 3 | 2018 | 15594 | 0.050 |
Why?
|
| Pilot Projects | 1 | 2022 | 909 | 0.040 |
Why?
|
| Aged, 80 and over | 2 | 2018 | 5043 | 0.040 |
Why?
|
| Office Visits | 1 | 2017 | 41 | 0.040 |
Why?
|
| RNA, Messenger | 1 | 2022 | 1460 | 0.040 |
Why?
|
| Cohort Studies | 1 | 2023 | 2428 | 0.040 |
Why?
|
| Inflammation | 1 | 2023 | 1091 | 0.030 |
Why?
|
| Cell Growth Processes | 2 | 2006 | 36 | 0.030 |
Why?
|
| Pregnancy | 1 | 2023 | 2325 | 0.030 |
Why?
|
| Psychometrics | 1 | 2017 | 352 | 0.030 |
Why?
|
| Adaptation, Psychological | 1 | 2017 | 260 | 0.030 |
Why?
|
| Feasibility Studies | 1 | 2017 | 512 | 0.030 |
Why?
|
| Academic Medical Centers | 1 | 2017 | 312 | 0.030 |
Why?
|
| Animals | 3 | 2006 | 19481 | 0.030 |
Why?
|
| Transfection | 2 | 2006 | 670 | 0.030 |
Why?
|
| Stress, Psychological | 1 | 2017 | 438 | 0.030 |
Why?
|
| Aged | 2 | 2018 | 13207 | 0.030 |
Why?
|
| Forecasting | 1 | 2013 | 217 | 0.030 |
Why?
|
| Informed Consent | 1 | 2013 | 129 | 0.030 |
Why?
|
| Cell Line, Tumor | 2 | 2006 | 1360 | 0.020 |
Why?
|
| Data Collection | 1 | 2013 | 381 | 0.020 |
Why?
|
| Middle Aged | 2 | 2018 | 16114 | 0.020 |
Why?
|
| Physician-Patient Relations | 1 | 2013 | 381 | 0.020 |
Why?
|
| Surveys and Questionnaires | 1 | 2017 | 2560 | 0.020 |
Why?
|
| Attitude of Health Personnel | 1 | 2013 | 554 | 0.020 |
Why?
|
| Young Adult | 1 | 2018 | 4270 | 0.020 |
Why?
|
| Capillary Permeability | 1 | 2006 | 14 | 0.020 |
Why?
|
| Placenta Growth Factor | 1 | 2006 | 15 | 0.020 |
Why?
|
| HCT116 Cells | 1 | 2006 | 49 | 0.020 |
Why?
|
| Dimerization | 1 | 2006 | 145 | 0.020 |
Why?
|
| Angiopoietin-1 | 1 | 2005 | 2 | 0.020 |
Why?
|
| Neoplasm Metastasis | 1 | 2006 | 194 | 0.020 |
Why?
|
| Neovascularization, Pathologic | 1 | 2006 | 137 | 0.020 |
Why?
|
| Neoplasm Transplantation | 1 | 2005 | 157 | 0.020 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2005 | 58 | 0.020 |
Why?
|
| Transplantation, Heterologous | 1 | 2005 | 221 | 0.020 |
Why?
|
| Mice, SCID | 1 | 2005 | 501 | 0.010 |
Why?
|
| Cell Movement | 1 | 2005 | 419 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2005 | 846 | 0.010 |
Why?
|
| Mice | 2 | 2006 | 10184 | 0.010 |
Why?
|
| RNA Interference | 1 | 2005 | 587 | 0.010 |
Why?
|
| Disease Progression | 1 | 2005 | 1029 | 0.010 |
Why?
|
| United States | 1 | 2013 | 7432 | 0.010 |
Why?
|
| RNA, Small Interfering | 1 | 2005 | 849 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2006 | 2039 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2005 | 2875 | 0.010 |
Why?
|